Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Bullboard Posts
Comment by bigreturn11on Feb 21, 2018 4:22pm
181 Views
Post# 27597257

RE:RE:RE:RE:RE:RE:RE:500,000 volume !!!

RE:RE:RE:RE:RE:RE:RE:500,000 volume !!!Maintaining >30% EBITDA margins while growing organically at 30-40% should easily command $4+ per share and quite a bit higher each subsequent quarter of solid results. 

....Insider options are set relatively low are there is significant incentive for mgmt to grow the business at this time.  Its full tilt promotion time and this company appears to have just mildly been discovered in the last couple days. I suspect that the conference call tells us that there are many irons in the fire - I wouldnt have expected an impromptu conference call to tell us anything otherwise.....the time is right to tell the story and the story is looking extremely rosy.

Without a doubt, I would expect to see some analyst targets of $7 to $9 as coverage is initiated. 
Bullboard Posts